| Application no. and date | 08807330.9 (espacenet) (Federated) (European Patent Register), 20080815 | | Patent/reg. no. and date | DK/EP 2190837, 20120815 | | Publication date | 20100602 | | Priority no. and date | WO PCT/IB2007/053292, 20070817, WO PCT/IB2008/052571, 20080626 | | EP pub. no. and date |
EP 2190837 20100602 | | Effective date | | | Applicant/owner | Idorsia Pharmaceuticals Ltd, Hegenheimermattweg 91
4123 Allschwil, CH | | Applicant ref. no. | P50322DK01 | | Inventor | BOLLI, Martin, Bachgrabenweg 21
CH-4123 Allschwil, CH,
BOSS, Christoph, Muesmattweg 89
CH-4123 Allschwil, CH,
TREIBER, Alexander, c/o Actelion Pharmaceuticals Ltd
Gewerbestrasse 16
CH-4123 Allschwil, CH | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/506 (2006.01) , A61P 25/00 (2006.01) , A61P 3/10 (2006.01) , A61P 9/00 (2006.01) , C07D 403/12 (2006.01) | | Title | 4-PYRIMIDINSULFAMID-DERIVAT | | Int. application no. | IB2008053282 | | Int. publication no. | WO2009024906 | | Related patent (certificate) | CA 2024 00046 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
